If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,750.00    75.00 (1.60%)
Bid:
4,700.00
Ask:
4,800.00
Spread: 100.00 (2.128%)
Market Cap: £316.38m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Acquisition

10 Jun 2009 07:00

RNS Number : 6409T
Judges Scientific PLC
10 June 2009
Β 

10Β JuneΒ 2009

JUDGES SCIENTIFICΒ plc

("JudgesΒ Scientific" or the "Company")

ACQUISITION OF QUORUM TECHNOLOGIES LIMITED

Judges ScientificΒ (formerly Judges Capital plc),Β the parent company ofΒ a group that specialises in the design,Β manufactureΒ and saleΒ of scientific instruments, announces that it has today completed the acquisition of theΒ entireΒ issued share capital of Quorum Technologies Limited ("Quorum"Β or the "Acquisition")Β for aΒ totalΒ consideration ofΒ up toΒ Β£1.5Β million.Β 

Quorum designs manufactures and distributes sample preparation instruments for use in electron microscopy. Imaging in electron microscopy generally requires samples to be electrically conductive in order to prevent a build up of electrical charges which would adversely affect the clarity of images. Typical sample preparation will involve some combination of cleaning, drying, coating or freezing prior to samples being introduced into the vacuum chamber of an electron microscope. Instruments produced by Quorum for sample freezing ("cryo") and transfer under vacuum are manufactured at the company's plant in Ringmer, East Sussex, while those used to coat non-cryo samples are primarily produced at its site in Ashford, Kent.

Quorum's products are marketedΒ principallyΒ under the Polaron and EmitechΒ brand names. Customers include manyΒ of the world's leadingΒ universities andΒ research and forensic laboratories,Β as wellΒ as the major manufacturers of electronΒ microscopes. Applications for the technology are to be found in all the life and materials sciences, as well as cutting-edge industrial technologies such as semiconductor production.

Quorum wasΒ foundedΒ in 2001 by Bob Kenhard and three colleaguesΒ through theΒ purchaseΒ ofΒ a small businessΒ engaged in the manufacture of the Polaron range of sample preparation instrumentsΒ fromΒ VG Systems Limited,Β a wholly-owned division ofΒ Thermo ElectronΒ Corporation.Β Polaron is a widely respected brand in theΒ field ofΒ electron microscopy,Β having been established at the vanguard of the growth in this technology during the 1960s.Β In 2005,Β QuorumΒ acquired the assets and trade of EmitechΒ Limited, a majorΒ UKΒ competitor and a significant brand in sample preparation.

Mr Kenhard,Β aged 61,Β will remain withΒ QuorumΒ for a period ofΒ up toΒ a year as Managing Director andΒ thereafterΒ asΒ aΒ consultant to ensure a smooth transition before hisΒ eventualΒ retirement.

Β 

Quorum's audited accounts for the year endedΒ 31 October 2008Β show sales of Β£4.0Β million,Β the majority of whichΒ wasΒ exported,Β on which the company generatedΒ operating profitsΒ ofΒ Β£749,000.Β Net tangible assetsΒ as atΒ 31 October 2008Β amounted toΒ Β£1.1Β million.Β Quorum'sΒ operating profits figure of Β£749,000Β includesΒ a number ofΒ items which, had Quorum been a part of the JudgesΒ Scientific group of companies duringΒ thatΒ financial year,Β would notΒ have beenΒ included. The Board of JudgesΒ ScientificΒ believesΒ thatΒ the exclusion ofΒ such itemsΒ wouldΒ have resulted in a lower operating profit for Quorum ofΒ approximatelyΒ Β£496,000.Β TheΒ Board expects theΒ Acquisition to be earnings-enhancing in the current year.

The initial considerationΒ for the AcquisitionΒ beingΒ paid by JudgesΒ isΒ Β£1.2Β millionΒ in cash. An additional payment will be made to reflect the working capital available at completion in excess of theΒ ongoingΒ requirementsΒ of the business.Β FurtherΒ consideration will be payable to the vendors based on Quorum'sΒ earnings before interest and tax ("EBIT")Β in the twelve months following completion;Β under this earnout arrangement,Β the vendors will receive three times the amount by whichΒ Quorum'sΒ EBIT exceeds Β£400,000 up to a maximum payment of Β£300,000.

The Acquisition has been financed out of surplus funds. The Bank of Scotland hasΒ agreedΒ (subject to the finalisation of documentation)Β to makeΒ available to JudgesΒ ScientificΒ a Β£4Β millionΒ term loan, of which Β£3Β millionΒ will beΒ drawn down toΒ refinance this acquisition and to refinanceΒ the Company'sΒ existing borrowing, of which approximately Β£1.7Β millionΒ remainsΒ outstanding. The additional Β£1Β millionΒ isΒ conditionallyΒ available to be drawn down in the event of furtherΒ M&AΒ activity. In addition, a Β£500,000 overdraft facility will continue to be availableΒ to the Company.

Alex Hambro, Chairman of JudgesΒ Scientific, commented: "I am delighted that we haveΒ acquiredΒ this attractiveΒ business without issuing shares and without incurring imprudent levels of debt. It is important to pursue our strategy of enhancing earningsΒ throughΒ the acquisition of niche businesses in our sectorΒ whileΒ adjusting ourΒ short termΒ ambitions to the realities of today's financial environment."

Enquiries:

David Cicurel, CEO, JudgesΒ Scientific: Tel: 01342 323 600

Pascal Keane, Shore Capital: Β  Β Β Tel: 020 7408 4090

Melvyn Marckus, Cardew Group: Β Tel: 07775 896 491

Web sites:

Judges Scientific: www.judges.uk.comΒ 

Quorum: www.quorumtech.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQUKUWRKNRNRAR
Date   Source Headline
13th Dec 20164:15 pmRNSDirector/PDMR Shareholding
13th Dec 20164:13 pmRNSDirector/PDMR Shareholding
13th Dec 20164:11 pmRNSDirector/PDMR Shareholding
29th Nov 20167:00 amRNSAcquisition of EWB Solutions Ltd
21st Nov 20165:40 pmRNSBlock listing Interim Review
9th Nov 20164:38 pmRNSDirector/PDMR Shareholding
9th Nov 20164:35 pmRNSDirector/PDMR Shareholding
9th Nov 20164:32 pmRNSDirector/PDMR Shareholding
20th Oct 20164:21 pmRNSHolding(s) in Company
17th Oct 20162:47 pmRNSHolding(s) in Company
7th Oct 20163:30 pmRNSDirector/PDMR Shareholding
7th Oct 20163:20 pmRNSDirector/PDMR Shareholding
7th Oct 20163:15 pmRNSDirector/PDMR Shareholding
3rd Oct 20167:00 amRNSTotal Voting Rights
20th Sep 20167:00 amRNSInterim Results
12th Sep 20162:50 pmRNSDirector/PDMR Shareholding
12th Sep 20162:30 pmRNSDirector/PDMR Shareholding
31st Aug 20167:00 amRNSTotal Voting Rights
10th Aug 20162:30 pmRNSDirector/ PDMR Shareholding
10th Aug 20162:30 pmRNSDirector/ PDMR Shareholding
9th Aug 20167:00 amRNSNotice of Results
29th Jul 201611:05 amRNSTR-1: Notification of Major Interest in Shares
26th Jul 20161:30 pmRNSDirector/PDMR Shareholding
20th Jul 20167:00 amRNSTrading Update
8th Jul 201610:20 amRNSDirector/PDMR Shareholding
29th Jun 20165:35 pmRNSDirector/PDMR Shareholding
8th Jun 20161:40 pmRNSDirector/ PDMR Shareholding
1st Jun 20167:00 amRNSTotal Voting Rights
25th May 20161:05 pmRNSResult of Annual General Meeting
25th May 20167:00 amRNSAGM Statement
16th May 20169:31 amRNSBlock listing Interim Review
9th May 20164:00 pmRNSDirector/PDMR Shareholding
5th May 20168:53 amRNSHolding(s) in Company
3rd May 20167:00 amRNSTotal Voting Rights
13th Apr 201611:32 amRNSDirector/PDMR Shareholding
7th Apr 20165:05 pmRNSDirector/ PDMR Shareholding
1st Apr 20162:28 pmRNSDirector/PDMR Shareholding
1st Apr 20167:00 amRNSAcquisition of Dia-Stron Limited
29th Mar 20167:00 amRNSAcquisition
22nd Mar 20167:00 amRNSFinal Results
9th Mar 20164:06 pmRNSDirector/PDMR Shareholding
8th Mar 20163:03 pmRNSHolding(s) in Company
1st Mar 20167:00 amRNSTotal Voting Rights
25th Feb 20162:00 pmRNSDividend Declaration
19th Feb 20164:31 pmRNSHolding(s) in Company
19th Feb 20164:29 pmRNSHolding(s) in Company
18th Feb 20167:00 amRNSAcquisition of CoolLED Limited
10th Feb 20162:11 pmRNSDirector/PDMR Shareholding
19th Jan 20167:00 amRNSTrading Statement and Notice of Results
7th Jan 20161:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.